Award recordCONTRACT

AVKARE LLC

PIID VA26317A0048· VHA· 437-FARGO VA MEDICAL CENTER (00437)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2017· $0 net obligations· UEI SFPGXE6XPS93· TN

Description

MODIFICATION IMMUNOHEMATOLOGY REAGENTS BPA (TRANSFUSION MEDICINE TESTING)

Base award description: IMMUNOHEMATOLOGY REAGENTS FOR TRANSFUSION MEDICINE TESTING

First action · last action
2017-06-20 · 2017-07-10
Transactions
2
First transaction's obligation
$0
Base + all options value (sum of deltas)
$20,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
SERVICE DISABLED VETERAN OWNED SMALL BUSINESS SET-ASIDE
Offers received
1
SDVOSB flag on record
Yes (self-representation)
Parent IDV
V797D30052
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2017-06-20 · this action $0 · running total $0Modification P00001 · 2017-07-10 · this action $0 · running total $0
  • Base2017-06-20+$0= $0
  • Mod P000012017-07-10+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-06-20+$0$0IMMUNOHEMATOLOGY REAGENTS FOR TRANSFUSION MEDICINE TESTING
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-07-10+$0$0MODIFICATION IMMUNOHEMATOLOGY REAGENTS BPA (TRANSFUSION MEDICINE TESTING)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI SFPGXE6XPS93)

AwardOffice · PSC / listingNet obligationsFY
36E79726D0036NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0031NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79726D0002NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36E79725D0046NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0027NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0020NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6550 from 437-FARGO VA MEDICAL CENTER (00437) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26318N0476SYSMEX AMERICA, INC437-FARGO VA MEDICAL CENTER (00437)$35,561FY2018
VA26317J1584CEPHEID437-FARGO VA MEDICAL CENTER (00437)$105,553FY2018
VA26317J1585CEPHEID437-FARGO VA MEDICAL CENTER (00437)$105,553FY2018
VA26317J1583CEPHEID437-FARGO VA MEDICAL CENTER (00437)$84,257FY2018
VA26317J1618ROCHE DIAGNOSTICS CORPORATION437-FARGO VA MEDICAL CENTER (00437)$75,653FY2018

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA26317A0048_3600 · retrieved 2026-09-26.